Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Protective Order in Federal C.R. Bard Vaginal Mesh Litigation, Bernstein Liebhard LLP Reports

The Firm is representing victims of alleged transvaginal mesh complications in the federal and state litigations established for claims involving products manufactured by American Medical Systems, Inc., C.R. Bard, Inc., Ethicon, Inc. and Boston Scientific Corp.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Bernstein Liebhard LLP | Consumer Injury Lawyers
We continue to hear from women who have suffered serious transvaginal mesh complications, allegedly due to pelvic mesh products marketed by C.R. Bard and other device manufacturers.

New York, New York (PRWEB) May 06, 2013

Transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuitclaims.com/) continue to move forward in federal litigations now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. On May 3rd, the Court issued a Stipulated Protective Order in the C.R. Bard vaginal mesh litigation that establishes procedures for the handling of potentially confidential information produced during discovery. (In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2187)

“We continue to hear from women who have suffered serious transvaginal mesh complications, allegedly due to pelvic mesh products marketed by C.R. Bard and other device manufacturers. We are pleased to see discovery continuing in this litigation, and look forward to the start of the first federal C.R. Bard bellwether trial next month,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for the C.R. Bard litigation.

Transvaginal Mesh Lawsuits
Vaginal mesh lawsuits have been mounting in courts throughout the country since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious transvaginal mesh complications over a three year period. In July 2011, the FDA issued an update to that alert, warning that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh in prolapse repair, including mesh erosion through vaginal tissue, infection, pain, and urinary problems. The FDA also modified the position it had taken in 2008 regarding frequency of these problems, stating in the alert that such injuries were not rare.*

In addition to the C.R. Bard litigation, several other consolidated proceedings established for vaginal mesh lawsuits are currently underway in the Southern District of West Virginia, including: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committee in these proceedings.

In addition to the federal transvaginal mesh litigations, consolidated proceedings are also underway in New Jersey Superior Court, Atlantic County, involving products manufactured by Johnson & Johnson’s Ethicon unit and C.R. Bard. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). In March, the nation’s first trial involving an Ethicon mesh product concluded in the New Jersey litigation, with the jury awarding more than $11 million to the plaintiff, including $7.76 million in punitive damages. Mr. Grand, who is serving as Co-Liaison Counsel in both New Jersey pelvic mesh litigations, also served on the trial team for that case. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))

Court documents indicate that the first trial in the federal C.R. Bard pelvic mesh litigation is scheduled to begin on June 11th. In July 2012, a California Superior Court jury awarded $5.5 million to a woman and her husband for transvaginal mesh complications she sustained following implantation with two C.R. Bard products. (Scott v. Kannappan, S-1500-CV-266034-WDE, Superior Court for Kern County, California, Bakersfield)

Victims of alleged transvaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. More Information regarding vaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.transvaginalmeshlawsuitclaims.com/